(Reuters) In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck. It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.
Buffett’s Berkshire pares drug holdings, sheds Axalta, Biogen
This entry was posted in Syndicated. Bookmark the permalink.
